Guillain-Barré Sendromu: Klinik, Tanı ve Güncel Tedavi Yaklaşımları

Hughes, R.A., Guillain‐Barré syndrome: History, pathogenesis, treatment, and future directions. European Journal of Neurology, 2024. 31(11): p. e16346.

Bellanti, R. and S. Rinaldi, Guillain‐Barré syndrome: a comprehensive review. European journal of neurology, 2024. 31(8): p. e16365.

Yao, J., et al., Progress in Guillain–Barré syndrome immunotherapy—a narrative review of new strategies in recent years. Human vaccines & immunotherapeutics, 2023. 19(2): p. 2215153.

Hernández-Jardón, C.H. and L. Velásquez-Pérez, Epidemiological and clinical aspects of Guilain-Barré syndrome, 2012-2022. Revista Médica del Instituto Mexicano del Seguro Social, 2024. 62(6): p. e6119.

Tarulli, A., Neurology: a clinician’s approach. 2020: Springer Nature.

Wakerley, B.R. and N. Yuki, Pharyngeal-cervical-brachial variant of Guillain–Barré syndrome. Journal of Neurology, Neurosurgery & Psychiatry, 2014. 85(3): p. 339-344.

Sejvar, J.J., et al., Guillain–Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, 2011. 29(3): p. 599-612.

Ghazanfar, H., et al., Significance of Brighton criteria in the early diagnosis and management of Guillain-Barré syndrome. Cureus, 2020. 12(5).

Susuki, K., et al., A Guillain-Barré syndrome variant with prominent facial diplegia. Journal of neurology, 2009. 256(11): p. 1899-1905.

Roodbol, J., et al., Diagnosis of Guillain–Barré syndrome in children and validation of the Brighton criteria. Journal of neurology, 2017. 264(5): p. 856-861.

Sun, T., et al., Peripheral blood and cerebrospinal fluid cytokine levels in Guillain Barré syndrome: a systematic review and meta-analysis. Frontiers in Neuroscience, 2019. 13: p. 717.

van Doorn, P.A., Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS). La Presse Médicale, 2013. 42(6): p. e193-e201.

Willison, H.J., B.C. Jacobs, and P.A. van Doorn, Guillain-barre syndrome. The Lancet, 2016. 388(10045): p. 717-727.

Walgaard, C., et al., Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. The Lancet Neurology, 2021. 20(4): p. 275-283.

Doets, A.Y., et al., Predicting outcome in Guillain-Barré syndrome: international validation of the modified erasmus GBS outcome score. Neurology, 2022. 98(5): p. e518-e532.